Alternate-day antipsychotic dosing for schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial looks at whether taking an antipsychotic every other day can keep symptoms controlled in adults with schizophrenia or another psychotic disorder. It may help some people avoid daily dosing, but it requires specific medication stability and screening checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have a diagnosis of schizophrenia spectrum or another psychotic disorder
- Speak and understand English well enough for study discussions and paperwork
- Be able to sign consent in writing after understanding study details
- For at least 3 months, your symptoms must be stable while taking one of these by mouth: risperidone, olanzapine, or paliperidone at a specific dose range
- You must be taking your current antipsychotic consistently (adherence), and have a negative pregnancy test if you can become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more intensive medication approach for schizophrenia (or related conditions) helps people who didn’t improve on their first tried medicine. Participants will usually switch medicines and be compared against “treatment as usual.”
This trial tests whether taking clozapine once a day (instead of twice a day) works safely for people with schizophrenia. It may help by simplifying your dosing schedule while closely monitoring your wellbeing.
This study looks at how a common antipsychotic medication (olanzapine) affects how the brain uses insulin in young women. It aims to understand weight gain and metabolic changes linked to these drugs.
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
This study tests whether gradually reducing the dose of antipsychotic medication is as safe and effective as staying on the current dose for people with stable schizophrenia spectrum disorder. It aims to personalize treatment to find the lowest effective dose for each person.
This study tests switching from a long-acting injectable antipsychotic (paliperidone palmitate) to daily oral antipsychotics in people with schizophrenia who are currently stable. The goal is to see if the switch helps maintain symptom control and improve daily functioning.
Hear when a new Schizophrenia and Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.